Apyx Medical Corp
APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31
Reports and events: 288 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2916:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031468 |
| 2026-08-0716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036557 |
| 2026-08-0617:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026346 |
| 2026-08-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026262 |
| 2026-07-2417:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034619 |
| 2026-06-2616:13 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001437749-26-021840 |
| 2026-06-1716:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-029081 |
| 2026-05-2116:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-018098 |
| 2026-05-1408:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-016885 |
| 2026-05-1108:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-016000 |
| 2026-05-0716:55 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015652 |
| 2026-05-0707:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015352 |
| 2026-03-1013:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-007471 |
| 2026-03-1007:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007420 |
| 2026-01-1208:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-001048 |
| 2025-12-1216:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-027481 |
| 2025-11-1916:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024279 |
| 2025-11-0610:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033499 |
| 2025-11-0607:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033456 |
| 2025-08-1316:00 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-023451 |
| 2025-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025422 |
| 2025-08-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025417 |
| 2025-06-2509:10 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001437749-25-021220 |
| 2025-05-1307:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016259 |
| 2025-05-0812:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015356 |
| 2025-05-0806:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015231 |
| 2025-04-2908:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013413 |
| 2025-03-1316:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-007521 |
| 2025-03-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-007383 |
| 2025-02-0616:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-003036 |
| 2025-01-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-000927 |
| 2025-01-0608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-000375 |
| 2024-11-0815:38 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034193 |
| 2024-11-0807:29 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044154 |
| 2024-08-1216:09 ET | 8-K | 5.07 Shareholder vote results | 0000719135-24-000042 |
| 2024-08-0817:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000719135-24-000038 |
| 2024-08-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000036 |
| 2024-06-2516:06 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000719135-24-000032 |
| 2024-05-0912:14 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000719135-24-000026 |
| 2024-05-0907:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-025058 |
| 2024-05-0907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000024 |
| 2024-05-0907:01 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000719135-24-000023 |
| 2024-04-0509:00 ET | SC 13D | Ownership report, active investor | 0000921895-24-000805 |
| 2024-04-0116:15 ET | SC 13D | Ownership report, active investor | 0001140361-24-016912 |
| 2024-03-2112:08 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000719135-24-000016 |
| 2024-03-2107:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000013 |
| 2024-02-2107:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-24-000008 |
| 2024-01-2208:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-24-000005 |
| 2024-01-0807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000003 |
| 2023-11-2816:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000719135-23-000066 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.